PeptideAgentAsk PeptideAgent
Peptide guide · Weight & Metabolism

Retatrutide: the evidence, status, and research questions.

Retatrutide guide to human and preclinical evidence, research uses, FDA status, sport status, primary sources, and key limits.

Published Evidence reviewed August 7, 20263 inspectable sources8 min read
01What is Retatrutide?02What is the evidence for Retatrutide?03What is Retatrutide being studied for?04Is Retatrutide FDA approved?05Is Retatrutide prohibited in sport?06What are the evidence limits for Retatrutide?

EVIDENCE TAKEAWAY

The short answer.

Retatrutide has meaningful randomized human evidence, but it should not be described as an available approved alternative to semaglutide or tirzepatide.

WHAT IS RETATRUTIDE?

Start with identity.

An investigational triple GIP, GLP-1, and glucagon receptor agonist in late-stage metabolic research.

Entity type
Peptide analog
Research category
Weight & Metabolism
Names and aliases
Retatrutide

HUMAN VS PRECLINICAL

What evidence exists for Retatrutide?

HUMAN EVIDENCE
4/5 · Late-stage investigational

Randomized Phase 2 trials are published and Phase 3 development is underway; the drug remains investigational.

PRECLINICAL EVIDENCE
3/5 · Mechanism supported

Preclinical work supports triple-receptor pharmacology, but human trials are the decision-relevant evidence.

RESEARCH INTENT

What is Retatrutide being studied for?

Current source-backed research areas include the topics below. Inclusion means the area is being investigated; it does not establish a treatment benefit.

  • 01Obesity
  • 02Type 2 diabetes
  • 03Liver fat
  • 04Cardiometabolic outcomes

U.S. REGULATORY STATUS

Is Retatrutide FDA approved?

Investigational and not FDA approved; FDA states retatrutide cannot be used in compounding under federal law.

SPORT STATUS

Is Retatrutide prohibited in sport?

Not specifically named in the 2026 List; athletes should verify current status before use.

Anti-doping rules and product ingredients can change. Athletes should verify the current official list and the exact product before making a real decision.

EVIDENCE LIMITS

What can the current record not establish?

COMMON SEARCH INTENTS

Reviewed questions about Retatrutide.

Evidence

What is the evidence for Retatrutide?

Retatrutide has meaningful randomized human evidence, but it should not be described as an available approved alternative to semaglutide or tirzepatide.

3 sources Research

What is Retatrutide being studied for?

Current source-backed research areas include Obesity, Type 2 diabetes, Liver fat, Cardiometabolic outcomes. These areas describe investigation, not established personal benefit.

3 sources FDA status

Is Retatrutide FDA approved?

Current U.S. status for Retatrutide: Investigational and not FDA approved; FDA states retatrutide cannot be used in compounding under federal law.

3 sources Sport status

Is Retatrutide prohibited in sport?

Current sport-status snapshot for Retatrutide: Not specifically named in the 2026 List; athletes should verify current status before use.

3 sources Evidence limits

What are the main evidence limits for Retatrutide?

Promising trial results do not establish approval, product quality outside trials, or suitability for an individual.

3 sources Decision question

What is currently being studied for visceral fat?

The evidence depends on the population and the question. An approved indication, obesity treatment, and investigational research should not be collapsed into one list.

9 sources

PRIMARY AND OFFICIAL SOURCES

Inspect the research behind this guide.

Human trialNew England Journal of Medicine / PubMed · 2023Triple-hormone-receptor agonist retatrutide for obesity — Phase 2PeptideAgent source record